Home > Formulary : Adult > Local Guidelines >
2. Cardiovascular System Guidelines
Anticoagulation Guidance
DOAC Decision Aid Tool for non-valvular AF
Summary of considerations when prescribing a DOAC in non-valvular AF
BNSSG Guidance on switching between oral anticoagulants (July 2022)
BNSSG ICS Warfarin Counselling checklist
BNSSG ICS DOACs Counselling checklist
Management of Subtherapeutic INR in the community
Management of High INR in the community.
INR Self-testing Position Statement for BNSSG
INR Self-testing Agreement for BNSSG
Renal Anticoagulant Guidelines:
Anticoagulation Patient Information
Apixaban
-
Apixaban - Patient Information (available in 22 non-English languages)
Dabigatran
Edoxaban
Rivaroxaban
-
Support for Patients with Atrial Fibrillation (available in 10 non-English languages)
-
Step 1 – Go to the following web address https://www.xarelto.co.uk/patients-atrial-fibrillation
-
Step 3 – Pick the required language
-
Antiplatelet Guidance
BNSSG Guidelines for the Prescribing of Antiplatelets
Heart Failure Guidance
Primary Care Heart Failure Treatment Guideline
Practical Guidance on how to use Heart Failure Medications
Traffic light: How to monitor renal function and potassium rises in stable Heart Failure
Use of Dapagliflozin & Empagliflozin (SGLT2i) in Patients with Heart Failure
See Endocrine System Guidelines page for the 'Advice on the use of SGLT-2 inhibitors in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease'
Lipid Guidance
Combined BNSSG Lipid Guidelines
Inclisiran Information for Primary Care
For guidelines relating to appliances and devices, including hosiery and garments, see 20. Appliances and Part IX